Genialis Presents Data at SITC 2023 on RNA-Based Biomarkers to Predict Immunotherapy Response
Genialis, the RNA-biomarker company, today announced new data detailing how RNA sequencing data can help elucidate tumor biologies that may be amenable to immunotherapies and targeted agents. The information was presented in two posters at the...